We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOGI icon
1076
Logitech
LOGI
$15.5B
– –
-5,441
Closed -$527K
LPX icon
1077
Louisiana-Pacific
LPX
$5.19B
– –
-7,880
Closed -$649K
LTH icon
1078
Life Time Group Holdings
LTH
$9.74B
– –
-23,104
Closed -$435K
MAR icon
1079
Marriott International
MAR
$101B
– –
-3,259
Closed -$788K
MBI icon
1080
MBIA
MBI
$282M
– –
-44,548
Closed -$245K
MCK icon
1081
McKesson
MCK
$99.5B
– –
-660
Closed -$385K
MCS icon
1082
Marcus Corp
MCS
$752M
– –
-12,206
Closed -$139K
MD icon
1083
Pediatrix Medical
MD
$2.15B
– –
-10,540
Closed -$79.6K
MDB icon
1084
MongoDB
MDB
$24.9B
– –
-3,540
Closed -$885K
MGA icon
1085
Magna International
MGA
$18.3B
– –
-21,095
Closed -$884K
MKL icon
1086
Markel Group
MKL
$25.2B
– –
-1,539
Closed -$2.42M
MNDY icon
1087
monday.com
MNDY
$3.47B
– –
-1,151
Closed -$277K
MNST icon
1088
Monster Beverage
MNST
$93.2B
– –
-11,995
Closed -$599K
MOH icon
1089
Molina Healthcare
MOH
$10.4B
– –
-3,796
Closed -$1.13M
MP icon
1090
MP Materials
MP
$7.68B
– –
-18,606
Closed -$237K
MRK icon
1091
Merck
MRK
$323B
– –
-18,344
Closed -$2.27M
MS icon
1092
Morgan Stanley
MS
$337B
– –
-22,755
Closed -$2.21M
MTDR icon
1093
Matador Resources
MTDR
$5.86B
– –
-4,618
Closed -$275K
MTSI icon
1094
MACOM Technology Solutions
MTSI
$20.1B
– –
-10,036
Closed -$1.12M
NET icon
1095
Cloudflare
NET
$94.3B
– –
-2,563
Closed -$212K
NGVT icon
1096
Ingevity
NGVT
$2.59B
– –
-4,962
Closed -$217K
NNI icon
1097
Nelnet
NNI
$4.81B
– –
-2,833
Closed -$286K
NSC icon
1098
Norfolk Southern
NSC
$77.1B
– –
-1,066
Closed -$229K
NTAP icon
1099
NetApp
NTAP
$33.3B
– –
-14,949
Closed -$1.93M
NTR icon
1100
Nutrien
NTR
$32.4B
– –
-38,902
Closed -$1.98M
42 43
44
45 46

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.